• Like

APAC Healthcare Outlook 2012 - 2015- What Comes Next

  • 5,751 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
No Downloads

Views

Total Views
5,751
On Slideshare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
278
Comments
3
Likes
6

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Asia Pacific Healthcare Outlook 2012- 2015 What comes next…. Reenita Das SVP Healthcare and Life sciences
  • 2. What’s Trending for 2012…2015 China will be the largest pharmaceutical and medical devices market in APAC. Half of the growth in healthcare will come from the “E7”.Mobile Health to become the biggest business model disruptor creating access for healthcare delivery on a mass basis especially in emerging economies. Healthcare expenditure in APAC will increase by 75%. Competition between Asian diagnostics companies and MNCs will spur innovation. Advanced medical technologies will be defined by "lower cost scaled down technology“, reverse innovation will help leapfrog cost barriers. Surprisingly India is expected to lag behind in all healthcare segments except in Pharmaceuticals. Gen Y is going to break down some of the organizational sclerosis that is clogging up our healthcare system. Health enhancements set to become one of the top 10 market places in healthcare. Higher proliferation of non - healthcare companies entering healthcare. 2
  • 3. Global Reflections from 2011 and the way forward… Healthcare becomes data driven and Patients will be customized. More Kings and Queens Healthcare The flood gate of the healthcare Evolves to focus on cost Silicon Valley system Become a versus outcomes of Health Marts: and the Hi-Tech Service Industry Mckesson leads industry gets “you’re the way to 1 billion involved in sick…we’re quick” 2011 consumerize healthcare healthcare 2015 seniors by 2020 and 2 billion by 2050 HomeMore “generics” – R & D spend is healthcare and The big Tidaltechnologies Gold Rush to $ 1.15 trillion up care givers Wave:providing same Emerging Markets: despite economic dominate the Performancevalue at lower Indonesia, Russia, recession agenda basedprice, stripped Mexico, Brazil, India, Diagnostics and Insurancedown feature sets Turkey and China – Monitoring will policies comprising 1/5th of become the the worldwide health golden goose care sales 3
  • 4. The Asian perspective…Mobile phone users will rise from 2.2 billion in 2011to 3.4 billion in 2015 Growth of mHealth will Asian hospitals APAC facilitate penetration of evolve to Healthcare healthcare services become global market sales brands comprises 35%APAC in 2015Healthcaremarket sales willaccount for 29% 2011 2015 Increase ofin 2011 green Multiple technology in partnerships manufacturing, between NGOs, logistics and private and healthcare government for Most countries delivery Asian disease in APAC would based R&D have Traditional medicine and implemented supplements Emergence of New EMR platforms gaining market markets: strength and Vietnam, Ind onesia, Laos, a Over half of the middle class recognition nd Myanmar in will be from the APAC region development of by 2020. Gen Y to drive how healthcare healthcare is delivered infrastructure 4
  • 5. APAC Healthcare Expenditure will increase 151% by 2020, while countries with the lowest projected growth rate will be UK, Italy, & Germany South Korea $127 billion CAGR 5.5% Japan USA $563 billion $3922 billion China CAGR 3.0% CAGR 4.6% $1446 billion CAGR 15.5% Hong Kong $20 billion CAGR 3.2% India Taiwan $331 billion $65 billion CAGR 14.5% CAGR 7.8% Indonesia Vietnam $47 billion $31 billion CAGR 8.1% CAGR 14.8% Malaysia Philippines $25 billion ThailandAPAC $26 billion $25 billion$2927 billion CAGR 8.4% CAGR 11.5% CAGR 8.4%151% increase 2010-2020CAGR 9.2% Singapore $23 billionG7 CAGR 9.6%$6147 billion50% increase 2010-2020CAGR 4.0% Australia $198 billionBRIC CAGR 3.0%$1958 billion212% increase 2010-2020CAGR 12.1% 5
  • 6. China and Japan Steal the Show by 2015Taiwan/Indonesia catching up in Tier 2 countriesIndia is disappointing despite the hype… TIER 1 Pharmaceuticals Medical Medical Healthcare Diagnostics & Biotechnology Devices Imaging ITTotal Market $ 389.4 bil $ 140.0 bil $ 13.4 bil $ 11.0 bil $8.2 bil Size (2015) 1 China China Japan Japan Japan 2 Japan Japan China China Australia 3 India Australia South Korea India Taiwan 4 South Korea South Korea Australia Australia China 5 Australia India India South Korea South Korea TIER 2 1 Taiwan Taiwan Taiwan Indonesia Hong Kong 2 Indonesia Malaysia Malaysia Malaysia Singapore 3 Thailand Thailand Philippines Thailand Malaysia 4 Philippines Indonesia Indonesia Hong Kong Philippines 5 Vietnam Philippines Thailand Vietnam Indonesia 6
  • 7. Global vs. APAC: The New FrontierIn 2011, APAC is estimated to be 28.5% of global market Global & APAC Healthcare Revenues US$ Bn, 2011-2015 1800.0 1600.0 CAGR Market Drivers 4.3% 1400.0 • By 2020, Chronic disease deaths in APAC will grow at 20%. 1200.0 • 15% of the 37 million deaths worldwide is 1060.7 1000.0 1017.5 related to Pandemic and epidemic diseases, 978.1 1/3 of such was from APAC. 928.8 800.0 895.6 • Private expenditures is increasing in China and India, private spending accounted for 600.0 49.9% and 67.2% respectively in 2009. CAGR 400.0 12.1% 491.7 562.1 200.0 356.5 396.4 440.1 Market Restraints 0.0 2011 2012 2013 2014 2015 • Per capita healthcare expenditure is far APAC Rest of the World below global average (lowest is Vietnam and ($ Billion) ($ Billion) Indonesia ). • Shortage of healthcare professionals. Health • By 2015 APAC could represent of global market care workers in APAC is 6.8 per 1,000 population, compared to 18.9 in Europe and 28.5 % APAC Share 34.6% 24.8 in the Americas in 2010. • Access to healthcare and distribution limited in emerging markets. 7
  • 8. Chronic disease volume and lack of preventive care in APAC- continuing to drive the Pharma market Healthcare Industry Size by Product (2011) Healthcare Industry Size by Product (2015) 1.6% 2.0% 1.6% 2.0% 23.2% 24.7% 2.5% 2.4% 70.7% 69.3% Medical Devices Medical Imaging Medical Devices Medical Imaging Pharmaceuticals & Biotechnology Healthcare IT Pharmaceuticals & Biotechnology Healthcare IT Clinical Diagnostics Clinical Diagnostics • Pharmaceuticals and Biotechnology segment is growing at 11.5% CAGR. • Medical devices is growing at 14.0% CAGR. • Clinical Diagnostics is growing at 11.4% CAGR. • Medical imaging is growing at 11.2% CAGR. • HIT is growing at 9.7% CAGR. 8
  • 9. Pharma market will grow at almost triple the rate compared with the restof the world, accounting for 1/3rd of total by 2015 Pharmaceuticals & Biotechnology, US$ Bn, 2011-20151,200.0 Market Drivers CAGR 3.8%1,000.0 • Increased long term use of multiple and specialized drugs for the aging population. • Enhanced health awareness and purchasing 800.0 power boosting over-the-counter purchase. 738.5 707.4 • Government support for generics/bio- 677.6 600.0 649.0 similars. 636.0 • Increased disease incidence boosted by availability and usage of new diagnostic 400.0 CAGR tools. 11.5% 200.0 346.1 389.4 252.1 278.4 309.4 0.0 Market Restraints 2011 2012 2013 2014 2015 APAC Rest of the World • Patent expiry of major pharmaceutical ($ Billion) ($ Billion) products. • Cost control measures by various governments. 28.4% APAC Share 34.5% • In markets with strong local manufacturing, government tenders favor local manufacturers. 9
  • 10. By 2015, China will become the largest market in APACIndia, Philippines, and Vietnam expected to enjoy double digit CAGR Asia Pacific Total Pharmaceutical Market 2011-2015 Japan CAGR 2% US$ 108 billion CAGR 21% US$ 100 billionChina US$ 184 billion CAGR 7% US$ 86 billion South Korea, Hong Kong, Taiwan US$ 20 billion US$ 15 billion CAGR 19% India CAGR 9.6% US$32 billion SEA US$ 16 billion US$ 23 billion US$ 16 billion CAGR 2% Australia US$ 12 billion US$ 11 billion Total Pharma market 2015 Total Pharma market 2011 10
  • 11. Growth opportunities lie in segments that offer innovative productsand services to save costs and prevent diseases APAC generics and bio-similars market 2015: ~US$ 203 bn Generics and China and India are the two biggest markets but Japan’s generic market will grow at CAGR of 0 Bio-similars 9% reaching 12.3 bn in 2015 Dengue Vaccine: current demand: 300-400 million; but supply is only: 100 million doses Most countries (except China, India, Japan) currently do not have the infrastructure to develop vaccines Vaccines HBV: US$ 1.2 bn; CAGR 15%; Pneumococcal Conjugate Vaccine: 442 mn (2010) double digit growth Influenza vaccine market: 425 mn CAGR 13.3% (Asia) [Malaysia: 27%, Philippines: 26%, Singapore: 22%] APAC Oncology market 2015: ~US$ 4.4 bn; up from US$ 3 bn in 2010 Oncology Growth from early diagnosis of cancers and targeted therapy in top 3 types of cancer: lung 0 cancer, breast cancer and colorectal cancer 11
  • 12. APAC Medical Devices Local Asian companies spur growth through low cost products Medical Devices Revenues, US$ Bn, 2011-2015400.0 Market Drivers350.0 CAGR 5.1% • By 2015, Cardiology market is expected to300.0 reach $18 billion.250.0 • Surgical procedures are growing at 12.0 %. 208.69 • Japan and South Korea lead MIS in 201.19 APAC, demand for MIS increasing in200.0 200.10 185.07 Singapore, Malaysia, Australia and 170.92150.0 Thailand, driving devices market. • Local Asian companies of CAGR100.0 14.0% Japan, China, Korea and Taiwan offering 140.0 cost effective products. 50.0 104.1 116.2 82.8 94.1 0.0 2011 2012 2013 2014 2015 APAC Rest of the World Market Restraints ($ Billion) ($ Billion) • Technology based pricing approval remains a hurdle. 26.3 APAC Market Share 36.6 • Public hospitals practice- lowest price bidding, leads to price war. • Inadequate training or certification for allied healthcare staff. 12
  • 13. By 2012, China’s medical device market size is expected to cross Japan and by 2015, China is expected to lead with 52% market share Asia Pacific Top 5 markets of total medical devices market 2011-2015China CAGR 22.6% Japan CAGR 5.0% US$ 34.8 billion US$ 32.5 billion US$ 42.3 billion US$ 73.4 billion South Korea CAGR 11.6% US$ 4.0 billion US$ 6.1 billionIndia CAGR 8.5% US$ 2.0 billion US$ 2.8 billion Australia CAGR 13.0% US$ 3.0 billion US$ 4.9 billion Country total market 2011 Country total market 2015 13
  • 14. Population of India, Indonesia, Malaysia, Vietnam, Philippines and Thailand together is estimated to be 1.69 billion but they together represent only 6.7% of the medical devices market In APAC, cardiology market is expected to reach $18bil by 2015, China leading with an incidence rate ofCardiology 2.6 mil per year. Number of surgeries in hospitals across APAC is estimated to grow at 12.0% by 2015.Anesthetics &Surgical Anesthetics in APAC growing at 12.4% alongside surgical procedures. Orthopedics market in APAC is growing at 5.0 % CAGR, while endoscopy and laparoscopy is growing atOrthopedics, 8.3% CAGR.& endoscopy Increase of awareness and availability of affordable, high quality MIS procedures drive these procedures. 0 14
  • 15. Medical ImagingChina is expected to own 30% of APAC market by 2015… Medical Imaging Revenues, US$ Bn, 2011-201545.0 CAGR40.0 4.3% Market Drivers35.0 • Increased demand for health screening.30.0 • Reverse innovation of customized Asian 28.49 medical imaging products to cater for25.0 27.54 26.19 different culture and population. 25.0020.0 24.04 • R & D in medical imaging allows technological advancement - Molecular15.0 Imaging, Drug therapy combined with CAGR Ultrasound.10.0 11.2% 12.2 13.4 5.0 8.8 9.8 11.0 0.0 Market Restraints 2011 2012 2013 2014 2015 • APAC Refurbished market for imaging APAC Rest of the World equipments is expected to reach 9% growth ($ Billion) ($ Billion) by 2015. • System interoperability hinders new systems 26.7 APAC Market Share 32.0 adoption in hospitals. 15
  • 16. Japan will continue to lead the APAC Medical Imaging Asia Pacific Top 5 markets of total medical imaging market 2011-2015 Japan CAGR 12.0%China CAGR 12.3% US$ 3.5 billion US$ 2.6 billion US$ 5.5 billion US$ 4.1 billion South Korea CAGR 11.8% US$ 0.7 billion US$ 1.1 billionIndia CAGR 7.4% US$ 0.5 billion US$ 0.7 billion Australia CAGR 6.2% US$ 0.6 billion US$ 0.7 billion Total country market 2015 Total country market 2011 16
  • 17. Mammography, MRI and PET scans in medical imaging is expected to rise; as incidence rate for diseases are growing in APAC Mammography is growing at 11.0% in APAC.Mammography In 2010, Breast Cancer ranked the second major cancer among 7 Asian countries with an incidence 0 rate of 190,000 cases. By 2015, Breast cancer incidence rate is expected to be 22 affected people per 100,000 population MRI market is projected to reach 11.6% CAGR in APAC between 2011-2015. Closed MRI systems in Japan represents the largest product category, accounting for an estimatedMRI market share of 82% in 2011. Very High Field MRI system is expected to increase in APAC as newer hospitals opt for high-tech imaging machines. In 2010, among 7 Asian countries , 960,000 new cases of various types of cancer have been reported.PET scan PET scans application is expected to rise. Screening for Neurological disorders and Multiple sclerosis are areas to penetrate. 0 17
  • 18. Japan will continue to lead the APAC market with more than 40% market share Diagnostics Revenues, US$ Bn, 2011-2015 Market Drivers CAGR 5.98% • Government efforts to standardize testing by regulating diagnostic testing and instruments. • MNCs setting up marketing and manufacturing bases in APAC and providing competition to local diagnostic companies. • Greater acceptance of technology by physicians and growing awareness of middle class patients. CAGR • The molecular diagnostics market is growing 11.44% by 42% in India and 22.7% in China. Market Restraints • Limited government budget for diagnostics. • Lack of awareness about healthcare insurance coverage for clinical tests. 14.5% APAC Share 17.2% • Highly price sensitive market. • Lack of awareness and accessibility of diagnostic testing in rural areas. 18
  • 19. China & India will be driving the growth of the Diagnostics market in the next 5 years… Asia Pacific Top 5 markets of total Diagnostics market 2011-2015China CAGR 17% Japan CAGR 8.7% US$ 1.9 billion US$ 3.2 billion US$ 3.7 billion US$ 4.5 billion India CAGR 16.1% US$ 421 million US$ 766 millionAustralia CAGR 6% US$ 494 million Korea CAGR 5.9% US$ 624 million US$ 449 million US$ 564 million Country total market 2011 Country total market 2015 19
  • 20. APAC HIT growing at global pace of 9.0%. Will APAC jump the curve? Healthcare IT Revenues, US$ Bn, 2011-201545.040.0 CAGR Market Drivers35.0 9.2% • Quality, regulatory and performance30.0 application growing at 11.0% CAGR.25.0 31.96 • Patient and Revenue cycle management 31.00 related application will drive HIT with 10.3%20.0 27.01 25.29 CAGR. 22.5015.0 • Departmental Systems market size is expected to be $ 875 million in 2011, growing10.0 CAGR at 7.1%. 9.7% 5.0 8.2 5.7 6.2 6.8 7.5 0.0 2011 2012 2013 2014 2015 APAC Rest of the World Market Restraints ($ Billion) ($ Billion) • System interoperability hinders market growth. APAC Market Share • Too many small vendors offering HIT 20.2 20.5 solutions. 20
  • 21. Japan & Australia leading the HIT market in 2015, Australia is growing faster and Taiwan is catching up… Asia Pacific Top 5 markets of total HIT market 2011-2015China CAGR 13.7% Japan CAGR 5.0% US$ 0.6 billion US$ 1.7 billion US$ 1.0 billion US$ 2.0 billion South Korea CAGR 7.4% US$ 0.3 billion US$ 0.4 billion Taiwan CAGR 11.4%Australia CAGR 10.7% US$ 0.7 billion US$ 1.3 billion US$ 1.2 billion US$ 2.0 billion Country total market 2011 Country total market 2015 21
  • 22. APAC HIT Top 3 areas for growth potential... Application Potential by Growth Rate Quality, Patient and Patient and Regulatory and Revenue Cycle Physician Performance Management Services APAC MARKET 11.03% 10.33% 10.00% CAGR CAGR CAGR Application Potential by Market Size in 2011 Healthcare Departmental EHR Interoperability Systems Platform $875 mil $725 mil $517 mil (7.11%) (5.40%) (2.98%) 22
  • 23. Where to place your bets in APAC: 2012- 2015 Japan S.Korea Preventive healthcare & China Thailand Wellness monitoring India Taiwan Malaysia Vietnam Singapore Indonesia Mobile Philippines Australia Healthcare EMR/ Biosimilars Robotic surgery EHR Vaccines Silver Industry Growth Equipment Hospital (home care) MIS Services Traditional pharmaceuticals Molecular Diagnostics Telemedicine Digital Imaging INNOVATION SUPER NORMALISATION LEADERSHIP TRIGGER GROWTH Time Source: Frost & Sullivan. 23
  • 24. Thank You24
  • 25. Asia Pacific Healthcare Delivery Outlook 2012 – 2015 At the cusp of transformation and consumerisationRhenu BhullerVP, Healthcare Asia PacificDecember 2011
  • 26. 2015…Delivery of health at homeConsolidation of retail healthcare service modelIntegration of primary and secondary healthcare facilities. Establishment of electronic medical records integratingprimary and secondary healthcareSatellite based hospital model using advanced medical technologies for increasing accessibility in rural areasHealthcare as a service industryInflux of non-traditional healthcare institutions investmentsNew models of Holistic healthcare hubs integrating tertiary care, wellness, aged care and clinical R&DIncreasing funding opportunity for medical tourism through expanded international medical insuranceDifferentiation of hospital models through specialty or holistic health platforms 26 “We Accelerate Growth”
  • 27. Rising middle and affluent income population fuelingmarket growth APAC Healthcare Delivery Market Size US$ Bn, 2011-2015 Market Drivers Market Restraints 500 CAGR 8.0% 450 420 • Aging & growing 390 400 362 • Manpower shortage Population 350 334 309 • Access disparity between • Rise in chronic disease 300 urban & rural regions 250 • Medical Tourism • Inability to meet demand 200 • Rising middle and affluent 150 of healthcare services in income population 100 smaller cities and rural 50 areas - 2011 2012 2013 2014 2015 Note: All figures are rounded; the base year is 2009 Source: Frost & Sullivan 27 “We Accelerate Growth”
  • 28. 300 new public hospitals by 2012 in ChinaProjected Number of Hospital Beds - 2015 China - 2015 Public:3,057,442 India - 2015 (CAGR:4.9%) Public:374,670 South Korea - 2015 (CAGR:1.6%) Private:191,038 Public: 68,745 (CAGR:2.1%) Private:270,098 (CAGR:1.8%) (CAGR:3.2%) Private: 482,436 Indonesia - 2015 (CAGR:4.2%) Public :1,07,796 (CAGR:4.3%) Private:60,813 (CAGR:3.9%) Philippines - 2015 Public:51,204 Thailand - 2015 Singapore - 2015 (CAGR:1.2%) Public:87,516 Public :9,867 (CAGR:2.1%) (CAGR:2.6%) Private: 58,524 (CAGR:3.0%) Private:36,820 Private :3,181 (CAGR:3.8%) (CAGR:1.8%) 28 “We Accelerate Growth”
  • 29. JCI accredited hospitals in APAC have increased byalmost 7-fold over the past 6 years International AccreditationsJCI Accredited Hospitals in Key Asian Countries, 2005 - 2011 • International accreditations (e.g. JCI) 2005 2011 JCI 2005 2011 likely to become the30 Accredited prerequisite for Hospitals 15 115 in Asia hospitals targeting to25 participate in medical 24 I tourism20 20 M • Stringent operational 17 P and stringent15 15 13 A accreditation 12 C requirements likely to10 9 9 T escalate the clinical and operational quality 5 5 standards, thus 2 2 increasing market 1 1 0 0 0 0 competitiveness 0 1 2 3 4 5 6 7 8 9 Msia Phil S. Korea India Taiwan China Spore Thai 29 “We Accelerate Growth”
  • 30. Hospital group consolidation to stretch beyond regionalborders Hospital Liberalisation of services sector under ASEAN Economic Community (AEC): Investors will be able to hold over 70 percent stake in four major services sectors, including healthcareConsolidation /diversification Hospitals are diversifying to increase competitiveness (e.g. Bangkok Dusit aggressive increase on investment in non-core medical businesses, from USD 16.6 mil to USD 133.3 mil) Year Region Description • More hospital group consolidation 2011 Singapore, • Several Institutional investors (including Temasek likely to stretch beyond regional Thailand Holdings) sold 5.85% stake in Bumrungrad borders Hospital I • More non-traditional healthcare 2011 Japan, • Mitsui acquired 30% stake in Integrated players are likely to acquire stakes Malaysia Healthcare Holdings (healthcare investment arm M in health institutions; or vice of Khazanah) P versa, where traditional hospital 2011 India, • Fortis Healthcare acquired Quality HealthCare A players are extended to other Singapore Asia in Hong Kong and Dental Corporation healthcare related fields (e.g. health Hong Kong C education, clinical research or • Fortis agreed to pay half a billion US Dollar to buy T medical device R&D) Singapore-based Fortis Healthcare International PTE from investment company RHC in Mauritius • New found risks and challenges due to operations in unfamiliar territories 2011 Singapore • Parkway Singapore plans to buy stake in Turkish Turkey hospital group Acibadem; Acibadem runs 11 general hospitals, 8 medical centers and a laboratory and genetic diagnostic center in Turkey 30 “We Accelerate Growth”
  • 31. Aging population driving the change in healthcare service Key Markets Healthcare Environments delivery India China Indonesia Malaysia Thailand Australia SingaporeAging Population No Yes No Yes Yes Yes YesDominant Distributer of Life/ Non Life/ Life/ Non Life/ Life Life Life Health LifePHI Health HealthTax Incentives for PHI Yes Group No Yes No Yes YesRestrictions on Premium Notify No No No No Yes notifyRatesGuaranteed Renewal Some Some No No No YesGroup biz as % of total 45% 30% >20% 30% 20% <10% 25%portfolio 31 “We Accelerate Growth”
  • 32. Singapore expected to achieved full EMR implementationby 2013“Paper-less Key MarketsHealthcare” Expected to achieved full EMR implementation (100% paperless) by 2013 Currently fully integrated EMR between hospitals and polyclinics Singapore Moving towards final phase of EMR integration with private GPs • Improved operational Pipeline: National Tele-health and cloud computing integration and cost efficiency for healthcare providers • Increased HCIT implementation undertaken at institutional levels ,as part of competitiveness for China’s USD 124 billion Healthcare Reform I medical tourism China High potential - Average 950 patients per physician per month M sectors (compared to 400 in the US) treated at more than 20,000 hospitals in P China and most of which are still maintaining paper based patient data • EMR implementation A is intended to enhance Government’s push for EMR penetration through pilot projects (e.g. C efficiency would pose U-Health) T new challenges to Adoption of EMR for tertiary hospitals has increased from 21.4% in healthcare operators S. Korea 2005 to 77.3% in 2010 Driven by 2008 Health Care Innovating Service Program Taiwan Taiwan Electronic Medical Record Template (TMT) to increase Interoperability for national-wide through a portable and interoperable infrastructure for EMR exchange 32 “We Accelerate Growth”
  • 33. Where to place your bets in APAC: 2012-2015 Asia Pacific Japan Preventive Healthcare Wellness S.Korea China Monitoring India Thailand Malaysia Indonesia Medical insurance portability Singapore Mobile Healthcare Vietnam Philippines Home Healthcare Australia Internationally Accredited Service Delivery Specialty based hospitals Healthcare Service Facilities vs. Holistic wellness hospitals Growth Retail healthcare service Satellite based hospital model Primary and Diagnostic Tier2 and Tier3 stand alone centers Healthcare Service Center development INNOVATION SUPER NORMALISATION LEADERSHIP TRIGGER GROWTH Time Source: Frost & Sullivan. 33 “We Accelerate Growth”
  • 34. Frost & SullivanAn Active Contributor to Global HC Market Development Comprehensive Supply-side Analysis Recognizing Best Practices Strategic Expert Analysis Hosting Industry Robust Forums End-user Thought Analysis Leadership 34 “We Accelerate Growth”
  • 35. Thank You 35 “We Accelerate Growth”
  • 36. Follow Frost & Sullivan onFacebook, LinkedIn, SlideShare, and Twitter http://www.facebook.com/FrostandSullivan http://www.linkedin.com/companies/4506 http://www.slideshare.net/FrostandSullivan http://twitter.com/frost_sullivan 36 “We Accelerate Growth”
  • 37. For Additional Information Donna Jeremiah Carrie Low Corporate Communications Corporate Communications Asia Pacific Asia Pacific +603 6204 5832 +603 6204 5910 djeremiah@frost.com carrie.low@frost.com Jessie Loh Corporate Communications Asia Pacific +65 6890 0942 jessie.loh@frost.com 37 “We Accelerate Growth”